Literature DB >> 1478722

HIV-2 antibodies in serum samples from Maharashtra state.

S Kulkarni1, M Thakar, J Rodrigues, K Banerjee.   

Abstract

Two hundred serum samples were tested to detect the presence of HIV-2 infection in Maharashtra state. The serum samples were derived from various groups including those with high risk behaviour for HIV infection. All samples were tested by three combined HIV-1 and HIV-2 ELISA kits. The reactivity was confirmed by LiaTek HIV 1+2 immunoblot. The study confirmed that HIV-2 infection exists in Maharashtra, as 14 samples showed antibodies to HIV-2 and 14 showed antibodies to both HIV-1 and HIV-2. Antibodies to HIV-2 or HIV-1 and HIV-2 were detected mainly in persons with high risk behaviour.

Entities:  

Keywords:  Asia; Blood Supply; Developing Countries; Diseases; Equipment And Supplies; Examinations And Diagnoses; Hematologic Tests; Hiv Infections; Hiv Serodiagnosis; India; Laboratory Examinations And Diagnoses; Laboratory Procedures; Population At Risk; Research Methodology; Research Report; Southern Asia; Viral Diseases

Mesh：

Substances：

Year:  1992        PMID： 1478722

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


  9 in total

1.  Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.

Authors:  A McKnight; C Shotton; J Cordell; I Jones; G Simmons; P R Clapham
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

2.  Molecular confirmation of human immunodeficiency virus (HIV) type 2 in HIV-seropositive subjects in south India.

Authors:  R Kannangai; S Ramalingam; K J Prakash; O C Abraham; R George; R C Castillo; D H Schwartz; M V Jesudason; G Sridharan
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 3.  Population migration and the spread of types 1 and 2 human immunodeficiency viruses.

Authors:  T C Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

4.  Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India.

Authors:  J J Rodrigues; S M Mehendale; M E Shepherd; A D Divekar; R R Gangakhedkar; T C Quinn; R S Paranjape; A R Risbud; R S Brookmeyer; D A Gadkari
Journal:  BMJ       Date:  1995-07-29

5.  Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo.

Authors:  J D Reeves; S Hibbitts; G Simmons; A McKnight; J M Azevedo-Pereira; J Moniz-Pereira; P R Clapham
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  Immune reconstitution and inflammatory syndrome due to disseminated tuberculosis in a case of human immunodeficiency virus 2 infection.

Authors:  M V S Subbalaxmi; A Krishna Prasad; M Shetty; V R Srinivasan
Journal:  Indian J Pharmacol       Date:  2011-05       Impact factor: 1.200

7.  Clinico-epidemiological and Socio-behavioral Study of People Living with HIV/AIDS.

Authors:  M A Khan; A Sehgal
Journal:  Indian J Psychol Med       Date:  2010-01

8.  Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai.

Authors:  Montaldo Chiara; Zachariah Rony; Mansoor Homa; Varghese Bhanumati; Joanna Ladomirska; M Manzi; N Wilson; Deshpande Alaka; A D Harries
Journal:  Indian J Med Res       Date:  2010-12       Impact factor: 2.375

9.  Phylogenetic Analysis of Human Immunodeficiency Virus Type 2 Group B.

Authors:  Eleonora Cella; Alessandra Lo Presti; Marta Giovanetti; Carla Veo; Alessia Lai; Giordano Dicuonzo; Silvia Angeletti; Marco Ciotti; Gianguglielmo Zehender; Massimo Ciccozzi
Journal:  J Glob Infect Dis       Date:  2016 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.